Genetic factors associated with drug-resistance of epilepsy: Relevance of stratification by patient age and aetiology of epilepsy

  title={Genetic factors associated with drug-resistance of epilepsy: Relevance of stratification by patient age and aetiology of epilepsy},
  author={M. Blanca S{\'a}nchez and Jos{\'e} Luis Herranz and Carlos Leno and Rosa Arteaga and Agust{\'i}n Oterino and Elsa Mar{\'i}a Valdiz{\'a}n and Josep Mar{\'i}a Nicol{\'a}s and Javier Ad{\'i}n and Juan A. Armijo},

Tables from this paper

ABCB1 Polymorphisms and Drug-Resistant Epilepsy in a Tunisian Population

The response to antiepileptics seems to be modulated by TT genotypes, T alleles, and the predicted haplotypes for the tested SNPs in the population.

CYP3A5∗3 and C3435T MDR1 Polymorphisms in Prognostication of Drug-Resistant Epilepsy in Children and Adolescents

The study failed to corroborate association between polymorphism CYP3A5∗3 and C3435T polymorphism in MDR1 gene and pharmacoresistant epilepsy and do not confirm the prognostic value of the polymorphisms examined in the prognostication of drug resistance in epilepsies.

Correlation between ABCB1 gene polymorphisms, antiepileptic drug concentrations and treatment response

In this study, an association of CT variant in ABCB1 C129T with lower AED plasmatic concentrations and no association betweenABCB1 variants and the drug responsiveness is found.

Correlation between ABCB 1 gene polymorphisms , antiepileptic drug concentrations and treatment response

Aim: A possible molecular mechanism of clinically defined multidrug-resistant epilepsy involves drug efflux transporters such as P glycoprotein (P-gp), a member of the ATPbinding cassette subfamily

Association analysis of intractable epilepsy with C3435T and G2677T/A ABCB1 gene polymorphisms in Iranian patients

Iranian adult female patients with a C/C genotype at position 3435 of the ABCB1 gene have a higher risk of resistance to antiepileptic drugs.

ABCB1 gene polymorphisms is not associated with drug-resistant epilepsy in Romanian children

The results show that MDR1 C1236T and G2677T polymorphisms are not associated with drug-resistant epilepsy in the study population, but 1236TT and 1236CT genotype variants and also 2677TT were found to be significantly associated withDrug-responsive idiopathic epilepsy.

Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis

Results indicate that ABCB1 C3435T polymorphism, especially TT genotype, plays an important role in refractory epilepsy and genetic screening of this genotype may be useful to predict AEDs response before starting the treatment, as further investigations should validate the association.

Polymorphism of ABCB1/MDR1 C3435T in Children and Adolescents with Partial Epilepsy is due to Different Criteria for Drug Resistance – Preliminary Results

The obtained results clearly confirm the lack of a connection between the occurrence of drug-resistant epilepsy and C435T polymorphism of the MDR1 gene irrespective of the definition of drug resistance applied to the patient.



Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1.

Patients with drug-resistant epilepsy were more likely to have the CC genotype at ABCB1 3435 than the TT genotype, implying that the polymorphism may not itself be causal but rather may be linked with the causal variant.

Various Pharmacogenetic Aspects of Antiepileptic Drug Therapy

Polymorphisms of drug targets may represent another genetic facet in epilepsy: a recent study demonstrated for the first time a polymorphism of a drug target associated in clinical practice with differing response to two classic AEDs.

ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.

It is demonstrated that ABCB1 polymorphisms may influence the AED responsiveness without significant changes in the plasma concentrations of CBZ, the inverse of previous results in European epileptics, thus the influence of ABCB 1 polymorphisms on the Aed responsiveness and/or the P-glycoprotein activity may vary among races.

The clinical impact of pharmacogenetics on the treatment of epilepsy

This article reviews the published work with particular emphasis on pharmacogenetic alterations that may affect efficacy, tolerability, and safety of antiepileptic drugs (AEDs), including variation in genes encoding drug target, drug transport, drug metabolizing, and human leucocyte antigen (HLA) proteins.

Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort study

Refractory Epilepsy: Clinical Overview

Pharmacogeneticists are currently attempting to understand the genetic basis of refractory epilepsy so that they can identify subgroups of patients who share a common genetic background and then target drug therapies to meet their specific needs.

The Role of Pharmacogenetics in the Metabolism of Antiepileptic Drugs

  • U. Klotz
  • Biology, Medicine
    Clinical pharmacokinetics
  • 2007
The traditional and validated therapeutic drug monitoring approach, representing a direct ‘phenotype’ assessment, still remains the method of choice when an individualised dosing regimen is anticipated, but pharmacogenetics and pharmacogenomics can offer some novel contributions when attempts are made to maximise drug efficacy and enhance drug safety.